HomeStock MarketWegovy’s coronary heart advantages aren't simply linked with weight reduction, new research...

Wegovy’s coronary heart advantages aren’t simply linked with weight reduction, new research suggests




Folks with obesity-related coronary heart failure and diabetes can get substantial heart-health advantages from weight-loss drug Wegovy, even when they don’t shed many kilos on the medicine, in line with new analysis.



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read